THE C-MYC PROMOTER-BINDING PROTEIN (MBP-1) AND TBP BIND SIMULTANEOUSLY IN THE MINOR-GROOVE OF THE C-MYC P2 PROMOTER

被引:47
作者
CHAUDHARY, D
MILLER, DM
机构
[1] UNIV ALABAMA, DEPT MED, DIV HEMATOL ONCOL, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, CTR COMPREHENS CANC, DEPT MOLEC GENET & BIOCHEM, BIRMINGHAM, AL 35294 USA
[3] VET AFFAIRS MED CTR, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1021/bi00010a036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-myc promoter binding protein (MBP-1) is a DNA binding protein which negatively regulates the expression of the human c-myc gene. MBP-1 binds to a sequence which overlaps; the binding site for the general transcription factor TBP, within the c-myc P2 promoter region. Since TBP binds in the minor groove, MBP-1 might inhibit c-myc transcription by preventing the formation of a functional preinitiation complex. In support of this hypothesis, we have demonstrated that MPB-1 is a minor groove binding protein. In order to characterize MBP-1 binding, we substituted A-T base pairs in the MBP-1 binding site with I-C base pairs, which changes the major groove surface without altering the minor groove surface. This substitution did not inhibit the sequence-specific binding of MBP-1 and TBP. On the other hand, G-C to I-C substitution within the MBP-1 binding site alters the minor groove and prevents MBP-1 binding. Competitive electrophoretic mobility shift assays were used to show that berenil, distamycin, and mithramycin, all of which bind in the minor groove, compete with MBP-1 for binding to the MPB-1 binding site. These minor groove binding ligands also effectively inhibit the simultaneous DNA binding activity of both MBP-1 and TBP. We conclude that both MBP-1 and TBP can bind simultaneously in the minor groove of the TATA motif on the c-myc P2 promoter. This suggests that MBP-1 may negatively regulate c-myc gene expression by preventing efficient transcription initiation.
引用
收藏
页码:3438 / 3445
页数:8
相关论文
共 50 条
[1]   2 TRANSCRIPTION FACTORS, NF-KAPPA-B AND H2TF1, INTERACT WITH A SINGLE REGULATORY SEQUENCE IN THE CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PROMOTER [J].
BALDWIN, AS ;
SHARP, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) :723-727
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   DIFFERENTIAL PROMOTER UTILIZATION BY THE C-MYC GENE IN MITOGEN-2-STIMULATED AND INTERLEUKIN-2-STIMULATED HUMAN-LYMPHOCYTES [J].
BROOME, HE ;
REED, JC ;
GODILLOT, EP ;
HOOVER, RG .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2988-2993
[4]   CRYSTAL-STRUCTURE OF A BERENIL-D(CGCAAATTTGCG) COMPLEX - AN EXAMPLE OF DRUG DNA RECOGNITION BASED ON SEQUENCE-DEPENDENT STRUCTURAL FEATURES [J].
BROWN, DG ;
SANDERSON, MR ;
GARMAN, E ;
NEIDLE, S .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (02) :481-490
[5]   DETECTION OF DRUG-BINDING TO DNA BY HYDROXYL RADICAL FOOTPRINTING - RELATIONSHIP OF DISTAMYCIN BINDING-SITES TO DNA-STRUCTURE AND POSITIONED NUCLEOSOMES ON 5S RNA GENES OF XENOPUS [J].
CHURCHILL, MEA ;
HAYES, JJ ;
TULLIUS, TD .
BIOCHEMISTRY, 1990, 29 (25) :6043-6050
[6]  
CIARROCCHI G, 1991, ANTICANCER RES, V11, P1317
[7]   THE MYC ONCOGENE - ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION [J].
COLE, MD .
ANNUAL REVIEW OF GENETICS, 1986, 20 :361-384
[8]   A BIFURCATED HYDROGEN-BONDED CONFORMATION IN THE D(A.T) BASE-PAIRS OF THE DNA DODECAMER D(CGCAAATTTGCG) AND ITS COMPLEX WITH DISTAMYCIN [J].
COLL, M ;
FREDERICK, CA ;
WANG, AHJ ;
RICH, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8385-8389
[9]  
CONS BM, 1989, ANTI-CANCER DRUG DES, V5, P93
[10]  
CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6